Alexander Muik

Alexander Muik is a seasoned expert in immunotherapy and immunomodulators, currently serving as Senior Director of Immunomodulators at BioNTech SE since June 2016, where previous roles included Director and Head of Immunomodulators as well as Scientist in Immunotherapy Development. Prior experience includes a postdoctoral position at Paul-Ehrlich-Institut focusing on cancer stem cell-targeted virus-based therapeutics, along with earlier roles at Medizinische Universität Innsbruck, Chemotherapeutisches Forschungszentrum "Georg-Speyer-Haus," and research positions at Harvard Medical School and Goethe-Universität Frankfurt. Alexander Muik holds a Ph.D. in Biochemistry and a Diploma in Biochemistry from Goethe University Frankfurt.